Abstract

Monoamine oxidase inhibitions are considered as important targets for the treatment of depression, anxiety, and neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases. This has encouraged many medicinal chemistry research groups for the development of most promising selective monoamine oxidase (MAO) inhibitors. A large number of plant isolates also reported for significant MAO inhibition potential in recent years. Differently substituted flavonoids have been prepared and investigated as MAO-A and MAO-B inhibitors. Flavonoid scaffold showed notable antidepressant and neuroprotective properties as revealed by various and established preclinical trials. The current review made an attempt to summarizing and critically evaluating the new findings on the quercetin and related flavonoid derivatives functions as potent MAO isoform inhibitors.

Highlights

  • Depression and anxiety are estimated as incapacitating mental disorders which impose a huge health burden globally

  • Docking methodologies revealed that the quercetin can thoroughly bind within the active site of the oxyethyldaidzein

  • The monoamine oxidase (MAO) inhibiting capacity of quercetin. This special character of OH and ring B found unique as compared to xanthones, doofnot require and catechol forFlavonoid the betterDerivatives restricting association with MAO

Read more

Summary

Introduction

Depression and anxiety are estimated as incapacitating mental disorders which impose a huge health burden globally. Alzheimer’s disease is indicated by nerve cells die in the cerebral cortex and accounts for 60 to 80 percent of dementia cases which affected more than 25 million people worldwide in 2000 and may eventually to increase to 114 million by 2050 [6,7,8,9]. General treatment of this disease is the utilization of dopaminergic agonists. The current review made an attempt to identify the MAO inhibition property of quercetin and related derivatives and establish the rational design of new MAOIs from this investigation

Chemistry and Therapeutic Journey of Quercetin and Related Derivatives
Flavanoids
Molecular Docking Studies of Quercetin and Related Flavonoid Derivatives
Molecular
Findings
Design of the out

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.